Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.49% | 14.87% | 29.06% | 34.07% | 12.04% |
| Total Depreciation and Amortization | -43.44% | -8.99% | 50.46% | 110.60% | 260.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.92% | 18.98% | -51.05% | -49.83% | -44.04% |
| Change in Net Operating Assets | -166.27% | -129.33% | -116.35% | -161.83% | -55.20% |
| Cash from Operations | 6.10% | 7.86% | 20.70% | 24.12% | 6.49% |
| Capital Expenditure | 95.36% | 31.91% | 66.87% | 80.97% | 80.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 176.72% | 208.42% | 296.08% | -116.11% | -176.89% |
| Cash from Investing | 175.52% | 205.55% | 273.93% | -120.14% | -184.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.09% | -99.12% | -98.80% | 1,144.90% | 4,123.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.09% | -99.12% | -98.80% | 1,144.90% | 4,123.87% |
| Foreign Exchange rate Adjustments | -- | -202.94% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.01% | 103.33% | 93.21% | -4.25% | -450.71% |